<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Genome-guided discovery of the first myxobacterial biarylitide Myxarylin reveals distinct C–N biaryl crosslinking in RiPP biosynthesis</dc:title><dc:creator>Hug,	Joachim J.	(Avtor)
	</dc:creator><dc:creator>Frank,	Nicolas A.	(Avtor)
	</dc:creator><dc:creator>Walt,	Christine	(Avtor)
	</dc:creator><dc:creator>Šenica Kavčič,	Petra	(Avtor)
	</dc:creator><dc:creator>Panter,	Fabian	(Avtor)
	</dc:creator><dc:creator>Müller,	Rolf	(Avtor)
	</dc:creator><dc:subject>myxobacteria</dc:subject><dc:subject>secondary metabolites</dc:subject><dc:subject>biarylitide</dc:subject><dc:subject>natural product discovery</dc:subject><dc:subject>RiPPs</dc:subject><dc:subject>genome mining</dc:subject><dc:subject>Myxarylin</dc:subject><dc:description>Abstract 
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a structurally
diverse group of natural products. They feature a wide range of intriguing post-translational
modifications, as exemplified by the biarylitides. These are a family of cyclic tripeptides found in
Planomonospora, carrying a biaryl linkage between two aromatic amino acids. Recent genomic analyses
revealed that the minimal biosynthetic prerequisite of biarylitide biosynthesis consists of only
one ribosomally synthesized pentapeptide precursor as the substrate and a modifying cytochrome-
P450-dependent enzyme. In silico analyses revealed that minimal biarylitide RiPP clusters are
widespread among natural product producers across phylogenetic borders, including myxobacteria.
We report here the genome-guided discovery of the first myxobacterial biarylitide MeYLH,
termed Myxarylin, from Pyxidicoccus fallax An d48. Myxarylin was found to be an N-methylated
tripeptide that surprisingly exhibits a C–N biaryl crosslink. In contrast to Myxarylin, previously
isolated biarylitides are N-acetylated tripeptides that feature a C–C biaryl crosslink. Furthermore, the
formation of Myxarylin was confirmed by the heterologous expression of the identified biosynthetic
genes in Myxococcus xanthus DK1622. These findings expand the structural and biosynthetic scope of
biarylitide-type RiPPs and emphasize the distinct biochemistry found in the myxobacterial realm.</dc:description><dc:date>2021</dc:date><dc:date>2021-12-21 16:38:59</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>134001</dc:identifier><dc:identifier>UDK: 575</dc:identifier><dc:identifier>ISSN pri članku: 1420-3049</dc:identifier><dc:identifier>DOI: 10.3390/molecules26247483</dc:identifier><dc:identifier>COBISS_ID: 90433027</dc:identifier><dc:language>sl</dc:language></metadata>
